Kedudukan dalam Saham
#40302
ObsEva S.A. is a biopharmaceutical company focused on developing and... ObsEva S.A. is a biopharmaceutical company focused on developing and commercializing groundbreaking therapies for women facing challenges in reproductive health and pregnancy. Its product pipeline includes Linzagolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist currently in Phase III clinical trials. Linzagolix is being evaluated for its efficacy in treating pain associated with endometriosis and heavy menstrual bleeding linked to uterine fibroids in pre-menopausal women. The firm is also progressing with Ebopiprant, an oral and selective prostaglandin F2a (PGF2a) receptor antagonist, which is in Phase II clinical trials as a once-daily treatment for preterm labor occurring between 24 and 34 weeks of gestational age. Additionally, ObsEva is developing Nolasiban, an oral oxytocin receptor antagonist in Phase I clinical trials, aimed at enhancing clinical pregnancy and live birth rates for women undergoing in vitro fertilization. ObsEva S.A. was founded in 2012 and maintains its headquarters in Geneva, Switzerland.
Harga Saham
$0.00156067
Disegerakkan terakhir: 2024-05-03
Perubahan (1 hari)
-72.69%
Perubahan (1 tahun)
0.00%
Perdagangan ObsEva S.A. (OBSN)
Harga OBSN dengan permodalan pasaran b
Modal pasaran bagi ObsEva S.A.(OBSN)
Modal Pasaran: $182.87K
Sehingga August 2026, ObsEva S.A. mempunyai modal pasaran sebanyak $182.87K. Ini menjadikan ObsEva S.A. syarikat ke-40302nd paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran ObsEva S.A. dari 2018 hingga 2026
OBSN berbanding dengan 5 teratas yang paling popular stocks
| Harga OBSN |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.470T
|
+2,990,873,720.70%
|
|
|
|
|
$4.467T
|
+2,442,701,067.69%
|
|
|
|
|
$4.174T
|
+2,282,654,012.20%
|
|
|
|
|
$3.700T
|
+2,023,290,497.62%
|
|
|
|
|
$2.854T
|
+1,560,822,624.29%
|
